Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-6.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -4.13% |
| 2024 | 12.16% |
| 2023 | 21.21% |
| 2022 | 56.00% |
| 2021 | 54.66% |
| 2020 | 0.65% |
| 2019 | 36.73% |
| 2018 | 3.56% |
| 2017 | -47.47% |
| 2016 | 41.66% |